The brain serotonin system in autism
Author:
Rodnyy Alexander Ya1, Kondaurova Elena M.1, Tsybko Anton S.1, Popova Nina K.1, Kudlay Dmitry A.23, Naumenko Vladimir S.1
Affiliation:
1. Federal Research Center Institute of Cytology and Genetics , Siberian Branch of Russian Academy of Sciences , Akad. Lavrentyeva Ave. 10 , Novosibirsk 630090 , Russia 2. NRC Institute of Immunology FMBA of Russia , Kashirskoe Highway 24 , Moscow 115522 , Russia 3. Sechenov’s University , 8-2 Trubetskaya Str. , Moscow 119991 , Russia
Abstract
Abstract
Autism spectrum disorders (ASDs) are among the most common neurodevelopmental diseases. These disorders are characterized by lack of social interaction, by repetitive behavior, and often anxiety and learning disabilities. The brain serotonin (5-HT) system is known to be crucially implicated in a wide range of physiological functions and in the control of different kinds of normal and pathological behavior. A growing number of studies indicate the involvement of the brain 5-HT system in the mechanisms underlying both ASD development and ASD-related behavioral disorders. There are some review papers describing the role of separate key players of the 5-HT system in an ASD and/or autistic-like behavior. In this review, we summarize existing data on the participation of all members of the brain 5-HT system, namely, 5-HT transporter, tryptophan hydroxylase 2, MAOA, and 5-HT receptors, in autism in human and various animal models. Additionally, we describe the most recent studies involving modern techniques for in vivo regulation of gene expression that are aimed at identifying exact roles of 5-HT receptors, MAOA, and 5-HT transporter in the mechanisms underlying autistic-like behavior. Altogether, results of multiple research articles show that the brain 5-HT system intimately partakes in the control of some types of ASD-related behavior, and that specific changes in a function of a certain 5-HT receptor, transporter, and/or enzyme may normalize this aberrant behavior. These data give hope that some of clinically used 5-HT–related drugs have potential for ASD treatment.
Funder
Russian Science Foundation
Publisher
Walter de Gruyter GmbH
Subject
General Neuroscience
Reference214 articles.
1. Abdelrahman, H.M., Sherief, L.M., Alghobashy, A.A., Abdel Salam, S.M., Hashim, H.M., Abdel Fattah, N.R., and Mohamed, R.H. (2015). Association of 5-HT2A receptor gene polymorphisms with gastrointestinal disorders in Egyptian children with autistic disorder. Res. Dev. Disabil. 36C: 485–490, https://doi.org/10.1016/j.ridd.2014.10.023. 2. Albert, P.R. and Vahid-Ansari, F. (2019). The 5-HT1A receptor: signaling to behavior. Biochimie 161: 34–45, https://doi.org/10.1016/j.biochi.2018.10.015. 3. Allan, A.M., Liang, X., Luo, Y., Pak, C., Li, X., Szulwach, K.E., Chen, D., Jin, P., and Zhao, X. (2008). The loss of methyl-CpG binding protein 1 leads to autism-like behavioral deficits. Hum. Mol. Genet. 17: 2047–2057, https://doi.org/10.1093/hmg/ddn102. 4. Al-Tawashi, A. and Gehring, C. (2013). Phosphodiesterase activity is regulated by CC2D1A that is implicated in non-syndromic intellectual disability. Cell Commun. Signal. 11: 47, https://doi.org/10.1186/1478-811x-11-47. 5. Amaral, D.G., Anderson, G.M., Bailey, A., Bernier, R., Bishop, S., Blatt, G., Canal-Bedia, R., Charman, T., Dawson, G., de Vries, P.J., et al.. (2019). Gaps in current autism research: the thoughts of the Autism Research Editorial Board and Associate Editors. Autism Res. 12: 700–714, https://doi.org/10.1002/aur.2101.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|